HSP may be a promising cancer treatment candidate (Table 5) because it demonstrates a cytotoxic mechanism against a variety of cancer cells, including breast [128], pancreatic [129], prostate [130], glioblastoma [131], liver [132], kidney [133], colon [134], lung [135], oral [136], [137], osteosarcoma [138], ovarian [139], thyroid [140], leukaemia [141], and other cancers [126]. This evidence concerns the gene HSP90B2P and glioblastoma.